Quince Therapeutics News

Quince Therapeutics | DEFA14A: Others

Apr 24 16:11 ET

Quince Therapeutics | DEF 14A: Definitive information statements

Apr 24 16:07 ET

Quince Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 11 16:41 ET

Quince Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 1 17:23 ET

Quince Therapeutics | 8-K: Current report

Feb 15 16:03 ET

Quince Therapeutics | 8-K: Current report

Jan 29 16:07 ET

Quince Therapeutics | 8-K/A: Current report (Amendment)

Jan 5 00:00 ET

Quince Therapeutics | 8-K: Current report

Jan 3 00:00 ET

Quince Therapeutics | 8-K: Current report

Dec 22, 2023 16:08 ET

Quince Therapeutics | 8-K: Current report

Dec 8, 2023 16:06 ET

Quince Therapeutics | 8-K: Current report

Oct 26, 2023 16:01 ET

Quince Therapeutics | 8-K: Current report

Oct 23, 2023 16:05 ET

Quince Therapeutics | 8-K: Current report

Sep 6, 2023 07:18 ET

Quince Therapeutics | 8-K: Current report

Aug 10, 2023 17:05 ET

Quince Therapeutics | 8-K: Current report

Jul 24, 2023 07:16 ET

Quince Therapeutics | 8-K: Current report

May 25, 2023 16:23 ET

Quince Therapeutics | DEFA14A: Others

Apr 14, 2023 16:08 ET

Quince Therapeutics | DEF 14A: Definitive proxy statements

Apr 14, 2023 16:06 ET

Quince Therapeutics | 8-K: Current report

Apr 5, 2023 17:05 ET

Quince Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 4, 2023 16:33 ET